Six-Transmembrane Epithelial Antigen of Prostate 4: An Indicator of Prognosis and Tumor Immunity in Hepatocellular Carcinoma.

Mi Ha JuEun Jeong JangSung Hwa Kang Young Hoon RohJin Sook JeongSong-Hee Han

Published in: Journal of hepatocellular carcinoma (2023)

Our data indicated that reduced STEAP4 expression was significantly associated with tumor aggressiveness and poor prognosis, possibly because of its link to various biological processes and induction of HCC immune evasion. Therefore, STEAP4 expression may serve as a potential prognostic biomarker for cancer progression and immunity, as well as a therapeutic target in HCC.

Keyphrases

poor prognosis
long non coding rna
prostate cancer
papillary thyroid
risk assessment
electronic health record
squamous cell
human health
data analysis
childhood cancer